Skip to main content
. 2023 Apr 28;11:e15242. doi: 10.7717/peerj.15242

Table 2. HRCT and PET/CT manifestations of different differentiations.

Tumor Characteristic Moderate differentiation (60) Poor differentiation (28) P Value
Acinar (48) Papillary (12) Micropapillary (11) Solid (17)
Nodule diameter (cm) 2.6 ± 1.3 2.2 ± 0.7 2.6 ± 0.6 2.8 ± 1.4 0.308
CT value (HU) 27.9 ± 9.2 28.7 ± 9.4 31.0 ± 7.0 31.3 ± 5.9 0.122
Radiological characteristics
Lobulation N (%) 41(85.4) 10(83.3) 7(63.4) 16(94.1) 0.977
Spiculation N (%) 29(60.4) 9(75.0) 9(81.8) 13(76.5) 0.153
Vascular convergence N (%) 29(60.4) 5(41.7) 11(100.0) 12(70.6) 0.020
Pleural contact N (%) 36(75.0) 12(100.0) 9(81.8) 14(82.4) 0.813
Pleural indentation N (%) 9(18.8) 2(16.7) 5(45.4) 7(41.2) 0.015
Air bronchiologram
Dilatation N (%) 14(29.2) 5(41.7) 5(45.4) 8(47.1) 0.180
Disruption N (%) 3(6.3) 1(8.3) 4(36.4) 0 0.447
Distortion N (%) 9(18.8) 2(16.7) 4(36.4) 7(41.2) 0.034
SUVmax 8.2 ± 5.2 5.3 ± 3.1 8.2 ± 3.1 10.7 ± 4.6 0.021
SUVmean 4.4 ± 3.2 2.5 ± 1.4 4.2 ± 2.1 5.9 ± 2.7 0.050
MTV 4.8 ± 6.2 2.1 ± 1.5 5.2 ± 3.9 8.2 ± 14.2 0.119
TLG 31.3 ± 47.5 8.6 ± 7.1 26.7 ± 20.8 65.3 ± 107.4 0.082

Notes.

SUVmax
maximum standard uptake value
SUVmean
mean standard uptake value
MTV
metabolic tumor volume
TLG
total lesion glycolysis

P value is for comparison of moderate differentiation (acinar and papillary) and poor differentiation (micropapillary and solid).

The measurement data between the two groups were tested by t test.

The counting data between the two groups were tested by chi-square.